Current Rheumatology Reviews

Editorial from Editor-in-Chief
pp. 272-272(1)
Author: R. Venuturupalli, Swamy

Editorial [Hot Topic: Signal Transduction in Rheumatology-From Bench to Bedside (Guest Editors: Mirit Amit Vazina and Zeev Estrov)]
pp. 273-274(2)
Authors: Estrov, Zeev; Amit Vazina, Mirit

Suppression of Erosive Arthritis by NF-κB Inhibitors
pp. 275-281(7)
Authors: Kubota, Tetsuo; Umezawa, Kazuo

NF-κB in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
pp. 282-287(6)
Author: Kubota, Tetsuo

IL-6 Signaling and its Blockade with a Humanized Anti-Interleukin-6 Receptor Antibody in Rheumatoid Arthritis: Advent of a New and Innovative Therapeutic Drug, Tocilizumab
pp. 288-300(13)
Authors: Ohsugi, Yoshiyuki; Kishimoto, Tadamitsu

“Something is Wrong in the Ras Kingdom“ - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
pp. 301-305(5)
Authors: M.J., Rapoport; O., Bloch; M., Amit-Vazina

Janus Kinase (JAK) Inhibitors in Rheumatoid Arthritis
pp. 306-312(7)
Authors: Yamaoka, Kunihiro; Tanaka, Yoshiya

Therapeutic Perspectives in the Antiphospholipid Syndrome
pp. 313-321(9)
Authors: Cervera, Ricard; Espinosa, Gerard

Ankylosing Spondylitis, HLA-B27, Klebsiella and “Popper Sequences“
pp. 322-331(10)
Authors: Ebringer, Alan; Rashid, Taha; Fielder, Mark; Wilson, Clyde